Ukko
Mountain View, US · Founded 2016 · Delaware corporation · 58 employees on LinkedIn · 7 known investors
Ukko develops immuno-therapeutics for life-threatening food allergies using a computational protein design platform. It applies AI and protein micro-engineering to create modified allergens that retrain the immune system to tolerate the allergen without triggering an allergic response.
Founders & leadership
Ukko was founded in 2016 by Anat Binur and Yanay Ofran.
AB
Anat BinurCo-founder
YO
Yanay OfranCo-founder
JW
Judith Weiss PaltielPhD, VP Development
Board
SB
Scott BradyBoard director
SK
Investors · 7
Reported raises · per SEC filings
Form D private placements$7.7M disclosed across 1 round · 2017
▶$7.7MraisedJul 2017 · 5 investors · OtherRule 506(b)
▶$7.7MraisedJul 2017 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Anat BinurExecutive Officer, Director
- Yanay OfranDirector
- Scott BradyDirector
- Samir KaulDirector
- Offering amount
- $7.7M
- Amount sold
- $7.7M
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Ukko do?
- Ukko develops immuno-therapeutics for life-threatening food allergies using a computational protein design platform. It applies AI and protein micro-engineering to create modified allergens that retrain the immune system to tolerate the allergen without triggering an allergic response.
- Who founded Ukko?
- Ukko was founded by Anat Binur, Yanay Ofran in 2016.
- Who are Ukko's investors?
- Ukko's investors include Israel Biotech Fund, Khosla Ventures, Sanara Capital, Western Technology Investment, Fall Line Capital, Leaps by Bayer, PeakBridge VC.
- How much funding has Ukko raised?
- Ukko has disclosed $7.7M raised across 1 round.
- Where is Ukko headquartered?
- Ukko is headquartered in Mountain View, US.